About the
HealthTech Activator

The HealthTech Activator provides healthtech innovators and early-stage businesses access to programmes and services targeted to their needs. The Activator’s aim is to provide a wraparound service, no matter where you are on your innovation journey.

The healthtech challenge

From Fisher & Paykel Healthcare’s famed ‘preserving-jar’ humidifier prototype, to Colin Murdoch’s invention of the disposable syringe, NZ has an impressive heritage when it comes to healthtech innovation.

Today, healthtech firms rank among some of NZ's most globally successful businesses and NZ's healthtech sector shows impressive growth potential.

Healthtech firms accounted for 11% of our top 200 technology businesses in 2019. In the 2020-21 financial year, healthtech firms generated an estimated $2.85 billion in revenue, demonstrating a seven-year compound annual growth rate of 13%.

The healthtech opportunity

Healthtech innovators, however, face some unique challenges on the path to commercialisation. These include stringent regulatory and clinical trial requirements, higher capital needs and longer commercialisation pathways.

And importantly, these needs haven’t typically been well catered for by existing, generalised business interventions and advice.

HealthTech Activator icon

The HealthTech Activator

To meet these challenges, Callaghan Innovation and the Consortium for Medical Device Technologies (CMDT), with support from the Ministry of Business, Innovation and Employment (MBIE), have developed the HealthTech Activator.

The Activator aims to deliver improved connectivity, and more seamless funding and capability-building programmes and services, for New Zealand healthtech businesses.

The HealthTech Activator also supports the implementation of the Ministry of Health’s New Zealand Health Research Strategy 2017–2027, by supporting transformative and innovative ideas in the health sector.

HTA by the numbers

550
+
HTA subscribers
10
HTA Events in the past year
100
+
Companies directed or supported

NZ healthtech by the numbers

11
%
of our top 200 technology businesses in 2019 were healthtech firms
$2.85
b
in revenue for the 2020-21 financial year
13
%
seven-year compound annual growth rate

Hear from our customers

Firstly, Callaghan Innovation gave us the flexibility to commit to development activity to get us started, and secondly it allowed us to put our money into areas that would make us successful.
Brian Ward – Chief Executive, Aroa Biosurgery
Callaghan Innovation has seriously accelerated our company development by connecting us to experts in our medical field in product and intellectual property development and commercialisation.
Garth Sutherland – CEO, The Insides Company
Case studies

Who can the HealthTech Activator help?

Commercialisation opportunities in healthtech spring from many sources: from scientists undertaking research in our universities and Crown Research Institutes, to clinicians working in our hospitals, to entrepreneurs who recognise an unmet need but who may have a limited healthcare background.

Opportunities can also present themselves at all development stages in our healthtech ecosystem: from a clinician with the kernel of an idea for a business, to an established company with products or services already in-market.

Could your business benefit from the HealthTech Activator?

Contact us
Vials in a lab

How does the HealthTech Activator help?

The HealthTech Activator can help with:

  • Advising on defining product/market fit
  • Assessing market readiness and creating an individualised support journey
  • Capital education and planning
  • Assisting with regulatory preparedness and reimbursement strategy
  • Clinical trials and validation

The HealthTech Activator draws on the collective experience and support of the many entities operating in NZ’s healthtech ecosystem. These include:

  • Government agencies and ministries
  • Industry networks
  • Capital and finance sectors
  • NZ health system
  • Universities and Centres of Research Excellence

The HealthTech Activator will also link to other commercialisation services provided by Callaghan Innovation and NZTE, such as:

  • Advisory services
  • Capability support
  • Providing local and international connectedness
  • Project Grants, Student Grants, Research and Development Loan Scheme, and the Research and Development Tax Incentive (RDTI)
  • Research and Technical Services support

Callaghan Innovation will also encourage the co-location of emerging healthtech businesses to aid their development.

How does it work?

So, you’re an entrepreneur, clinician or scientist with a smart healthtech idea. What next?

How do you find out if there’s a market for that idea or what funding and capability support is available, or find funders who might back your idea?

The Healthtech Activator can help.

We can provide access to the advice, education, services and support you need, including:

  • Assessing product-market fit
  • Refining your proposition to make it ‘investor-ready’
  • Connecting you with the people and places, such as incubators, that can help turn your idea into a real product or service
  • Connecting you to the right funding channels
Contact us
Two men inspecting a robotic hand

Let us help you help others

If you have a vision to improve people’s health, let us help accelerate your healthtech innovation. Get in touch with the HealthTech Activator team here:

Contact us

About our partner

Callaghan Innovation is leading the HealthTech Activator, working closely with the Consortium for Medical Device Technologies.

The Consortium for Medical Device Technologies (CMDT) was established to help grow the medical device industry in NZ. The CMDT is a national resource linking research activities at NZ Universities and Crown Research Institutes and agencies with companies, healthcare providers, regulatory and industry bodies, the Health Innovation Hub, and the Commercialisation Partner Networks.
To strengthen connection and collaborations within the MedTech innovation ecosystem, the CMDT have developed the following strategic initiatives: Te Tītoki Mataora, the BioBridge, and Women in HealthTech.